For awhile I’ve been saying I wish CYDY has started the phase 2 for GvHD. If I remember correctly, it’s a fairly inexpensive phase 2 and wouldn’t take an extended period of time or that many patients.

Maybe, or hopefully, if CYDY can get some more cash with a NASH deal they can get GvHD going. But then again, the mono trial is also on hold.